Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Vertex Pharma

Roche - Basel

Roche signs $1bn-plus cancer deal with Molecular Partners

Partnership could create new type of drug conjugate similar to ADCs

- PMLiVE

Roche CMO joins Google health venture Calico

Hal Barron among four new appointments

Roche - Basel

EU backs Roche’s Kadcyla in breast cancer

Green light for Herceptin follow-up

Roche - Basel

Roche cuts $1bn deal on cancer therapy with Immatics

Licenses series of early-stage oncology immunotherapy programmes

- PMLiVE

Roche names head of European comms

Promotes Susie Hackett

- PMLiVE

FDA clears Roche’s breakthrough drug Gazyva

First drug approved in US under new scheme

Roche - Basel

Roche signs €400m superbug deal

Buys rights to investigational antibiotic from Polyphor

- PMLiVE

Roche signs biologics partnership with Samsung

Manufacturing deal follows investment in pharma firm's own capabilities

- PMLiVE

Amgen buys total filgrastim rights from Roche

Wrests control of white blood cell stimulator franchise

Roche Basel Switzerland

Roche invests $879m in its biologics future

Expects to create around 500 new jobs in Switzerland, Germany and the US

- PMLiVE

NICE backs Roche’s MabThera in rare autoimmune disease

Overturns previous negative draft guidance from England's cost-effectiveness body

- PMLiVE

FDA gives green light to Roche for early Perjeta in breast cancer

Oncology drug can now be used before surgery in the US

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links